Skip to content
Search

Latest Stories

UK economy grew more slowly than thought before Omicron hit

UK economy grew more slowly than thought before Omicron hit

BRITAIN'S economy grew more slowly than previously thought in the July-September period, before the Omicron variant of the coronavirus posed a further threat to the recovery later in the year, official data showed on Wednesday (22).

Gross domestic product in the world's fifth-biggest economy increased by 1.1 per cent in the third quarter, weaker than a preliminary estimate of growth of 1.3 per cent as global supply chain problems weighed on manufacturers and building firms.

That was slower than the economy's 5.4 per cent bounce-back in the second quarter when many coronavirus restrictions were lifted, the Office for National Statistics said.

Investors are braced for a further slowdown in the fourth quarter of 2021 and a weak start to 2022 due to a rise in Covid cases caused by Omicron which has hurt Britain's hospitality and leisure sector and hit retailers.


EXCLUSIVE: As Omicron surge continues doctors’ leaders warn…NHS ON BRINK OF COLLAPSE


Prime minister Boris Johnson has ruled out new Covid restrictions in England before Christmas but said he might have to act afterwards. Scotland and Wales have tightened controls.

"Although the economy has got better at coping with restrictions with each new wave, the possibility of tighter restrictions in January is further darkening the outlook for GDP," Bethany Beckett, an economist with consultancy Capital Economics, said.

The ONS said households dipped into their lockdown savings to finance their spending. The savings ratio fell to 8.6 per cent of disposable income, down from almost 11 per cent in the second quarter.

Weakness in the health sector, where test and trace work and vaccinations tailed off, and among hairdressers were partly behind the cut to the third-quarter growth estimate.

A fall in energy output, after a surge in demand during a cold spring in the second quarter, also weighed.

"However, stronger data for 2020 means the economy was closer to pre-pandemic levels in the third quarter," ONS Director of Economic Statistics Darren Morgan said.

The slump in Britain's economy last year was now estimated at 9.4 per cent, revised from a 9.7 per cent crash, and the ONS believed GDP in September was 1.5 per cent below where it was at the end of 2019, revised up from the previous estimate of 2.1 per cent.

However, Britain's progress towards regaining its pre-pandemic economic size, in inflation-adjusted terms, remained behind that of most other big rich economies such as France, Germany and the United States, the ONS said.

Business investment fell by 2.5 per cent in the third quarter from the previous three months and was nearly 12 per cent below its pre-pandemic level.

The Bank of England is hoping for a revival of business investment to help improve Britain's longer-term growth prospects.

Britain's balance of payments deficit widened to 24.4 billion pounds ($32.35 billion) as goods exports fell, goods imports grew and foreign companies received more income from their investments in the United Kingdom.

Economists polled by Reuters had expected a smaller deficit of 15.6 billion pounds.

As a share of GDP, the shortfall almost doubled to 4.2 per cent from 2.3 per cent in the second quarter.

(Reuters)

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less